Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas

Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas

Prolactinomas are the most common hypersecretory pituitary adenoma. The traditional first-line therapy is dopamine agonists (DAs), which are highly effective and tolerated in the majority of cases. However, DAs have the potential for psychiatric complications, such as psychosis, impulse control diso...

Full description

Saved in:
Bibliographic Details
Main Authors: Edward Mignone, Alistair K Jukes, Rowan Valentine, Richard Allison, Sunita M C De Sousa
Format: Article
Language:English
Published: Bioscientifica 2025-01-01
Series:Endocrine Oncology
Subjects:
aripiprazole
prolactinoma
cabergoline
neuroendocrinology
Online Access:https://eo.bioscientifica.com/view/journals/eo/5/1/EO-24-0065.xml
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items